PHRX Overall Average: 40% Buy
Stock Message Board http://investorshangout.com/search?q=PHRX&...mp;yt1=Go!
Last Updated: Friday, December 13, 2013 11:30:44 PM
Pharmagen, Inc. PHRX Current Price and Quotes
Last Price 0.007
Previous Close 0.0058 Open 0.0055
Daily Range 0.007 - 0.0055 52wk Range 0.095 - 0.003
Volume 1,264,626 Dividend N/A
Average Vol (3m) 1,779,299 Yield N/A
Pharmagen, Inc. PHRX
Company Information
9337 Fraser Avenue
Silver Spring, MD 20910
Website: http://www.pharmageninc.com
Phone: 204-898-8160
Email: info@pharmagenrx.com
Pharmagen, Inc. PHRX
With a multi-faceted approach, Pharmagen, Inc. is meeting the demands of the health provider market through dynamic, independent wholesale, compounding/admix, and innovative IT solutions. Nationally focused, we are a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins to the healthcare provider market. The Food and Drug Administration continues to see an increasing number of shortages, especially those involving sterile i...
Pharmagen, Inc. PHRX
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001470915
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 1000 - Metal Mining
Business Status Development Stage Company a/o Feb 22, 2012
Incorporated In: NV, USA
Year of Inc. 2009
Employees 13 a/o Feb 22, 2012
Company Officers/Contacts
Mackie Barch CEO, Secretary
Eric Clarke CFO
Company Directors
Mackie Barch
Company Notes
Formerly=Sunpeaks Ventures, Inc. until 1-2013
Service Providers
Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States
Legal Counsel
Clyde Snow & Sessions
Attn: Brian A. Lebrecht
Salt Lake City, UT, 84111
United States
Investor Relations Firm
Not Available
Pharmagen, Inc. PHRX
PHRX Security Details
Share Structure
Market Value1 $2,701,972 a/o Dec 13, 2013
Shares Outstanding 385,995,995 a/o Nov 12, 2013
Float 145,500,750 a/o Feb 22, 2012
Authorized Shares 550,000,000 a/o May 11, 2012
Par Value 0.001
Shareholders
Shareholders of Record 136 a/o Apr 01, 2013
Security Notes
Capital Change=shs increased by 45 for 1 split, payable upon surrender.. Pay date=12/07/2011.
Short Selling Data
Short Interest 38,942 (-13.66%)
Nov 29, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Pharmagen, Inc. PHRX Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Jun 30, 2011 Jun 30, 2010
Total Revenue 4,261 863 - -
Cost of Revenue 2,996 454 - -
Gross Profit 1,265 409 - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 3,361 692 69 81
Non-Recurring Items - - - 10
Other - - - -
Operating Income (2,096) (283) (69) (91)
Income From Continuing Operations
Add'l Income/Expense Items 90 - 1 -
Earnings Before Interest and Tax (2,006) (283) (69) (91)
Interest Expense 765 14 5 4
Earnings Before Tax (2,771) (297) (74) (95)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,771) (297) (73) (95)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,771) (297) (74) (95)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,771) (297) (74) (95)
Pharmagen, Inc. PHRX Recent News
Nov 14, 2013 Pharmagen Announces Third Quarter 2013 Results
Nov 13, 2013 Pharmagen to Attend 19th Annual Scientific Meeting of SMSNA
Nov 6, 2013 Pharmagen Announces Food and Drug Administration Registration
Oct 31, 2013 Pharmagen Announces Shift In Growth Strategy
Oct 23, 2013 Pharmagen Announces Clotamin® Now Available at CVS.com
Oct 9, 2013 Pharmagen Announces Hiring of Quality Control Manager
Sep 26, 2013 Pharmagen Announces Clotamin® Now Available at CVS